Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004	Mar 31, 2003
Prescription drugs	5.50B	5.78B	6.58B	6.67B	6.69B
Prescription drugs Growth	-4.78%	-12.11%	-1.44%	-0.19%	-1.83%
OTC Drugs	1.95B	1.91B	-	-	-
OTC Drugs Growth	2.43%	-	-	-	-
Special Contracts	1.93B	1.94B	-	-	-
Special Contracts Growth	-0.60%	-	-	-	-
Others	48.70M	85.00M	1.11B	1.27B	1.25B
Others Growth	-42.70%	-92.35%	-12.39%	1.74%	3.91%
Corporate	-1.87M	-45.00M	-32.24M	-53.23M	-58.21M
Pharmaceutical and Cosmetic Products	-	-	2.12B	2.19B	2.30B
Pharmaceutical and Cosmetic Products Growth	-	-	-3.25%	-4.48%	-3.24%
Total	9.43B	9.67B	9.78B	10.08B	10.17B
Total Growth	-2.43%	-1.11%	-3.01%	-0.87%	-1.54%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004	Mar 31, 2003
Japan	9.43B	9.67B	9.78B	10.08B	10.17B
Japan Growth	-2.45%	-1.10%	-3.01%	-0.87%	-1.54%
Total	9.43B	9.67B	9.78B	10.08B	10.17B
Total Growth	-2.45%	-1.10%	-3.01%	-0.87%	-1.54%

Source: S&P Global Market Intelligence.